Level Bio AB (publ) (NGM: LEVBIO)
Health Care · Life Sciences Tools & Services · SE
Skr0.22
-11.48% today · -38.3% 1Y
Level Bio AB (publ) (NGM: LEVBIO) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.48M.
Over the last twelve months the share price has lost 38.3%, trading between 0.22 and 0.45.
Tweenvest scores Level Bio AB (publ) across four factors: quality 56/100, value 65/100, growth 0/100. Its strongest factor is value.
LEVBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.48M
- Revenue (TTM)
- $3.55M
- P/E
- 3.11
- EPS
- 0.07
- Dividend yield
- —
- Beta (5Y)
- 1.44
- 52-week high
- Skr0.45
- 52-week low
- Skr0.22
- Avg volume (3M)
- —
- Shares outstanding
- 68.40M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Samsrita Labs LimitedBSE: 539267 | $2.77M | Rs11.80 | +0.34% |
| Innovotech Inc.TSXV: IOT | $2.48M | CA$0.07 | 0.00% |
| Cannabis Bioscience International Holdings, Inc.OTCPK: CBIH | $1.95M | $0.00 | -20.00% |
| Vanta Bioscience LimitedBSE: 540729 | $1.51M | Rs20.42 | -4.98% |
| Magle Chemoswed Holding AB (publ)OM: MAGLE | $1.22M | Skr0.40 | -0.50% |
| CDT Equity Inc.NasdaqCM: CDT | $807.40K | $0.64 | -10.21% |
| Attana AB (publ)NGM: ATANA | $774.24K | Skr0.00 | +50.00% |
| BNB Plus Corp.OTCPK: BNBX | $743.67K | $0.12 | -14.32% |
Figures last refreshed Oct 11, 2026.